Free tool
FAERS Monitor: Ammonia N 13
Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022119 or its brand name (Ammonia N 13, Ammonia N-13). Reports on generic versions are filed under their own applications.
Reports
57
Serious
43
75% of reports
Hospitalization
25
Death reported
8
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug abuse7
- cough6
- depression6
- drug ineffective6
- chest pain5
- dyspnoea5
- nausea5
- suicide attempt5
- vomiting5
- accidental exposure to product4
- drug hypersensitivity4
- eye irritation4
- eye pruritus4
- gastritis4
- loss of personal independence in daily activities4
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 9 |
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,102 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| gastritisSignal | 4 | 56.1 | 21.8 | 165 |
| eye pruritusSignal | 4 | 43.9 | 17.1 | 128 |
| drug abuseSignal | 7 | 31.0 | 15.5 | 175 |
| loss of personal independence in daily activitiesSignal | 4 | 30.7 | 11.9 | 87 |
| suicide attemptSignal | 5 | 30.4 | 13.2 | 115 |
| eye irritationSignal | 4 | 25.6 | 10.0 | 72 |
| accidental exposure to productSignal | 4 | 14.3 | 5.6 | 37 |
| chest painSignal | 5 | 10.0 | 4.3 | 32 |
| depressionSignal | 6 | 9.7 | 4.6 | 39 |
| coughSignal | 6 | 7.9 | 3.7 | 30 |
| drug hypersensitivitySignal | 4 | 7.6 | 3.0 | 17 |
| vomitingSignal | 5 | 3.9 | 1.7 | 8 |
| dyspnoeaSignal | 5 | 3.3 | 1.4 | 6 |
| nausea | 5 | 2.3 | 1.0 | 3 |
| drug ineffective | 6 | 1.7 | 0.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.